CoSec Acquired by International Corporate Services Provider Acclime
Date Posted – 22 March 2021 CoSec was acquired by international corporate services provider Acclime in a strategic move by both companies to expand operations internationally. Acclime has a strong and growing presence in nine key Asian jurisdictions…
John Brumby to lead $2b research fund in Victoria
Date Posted – 19 March 2021 Article Written – 18 March 2021 Written by Patrick Durkin, BOSS Deputy Editor Former Victorian Premier John Brumby will lead a new $2 billion research fund to turn good ideas into businesses…
Brisbane startup says it can make mRNA vaccines for Australia
Date Posted – 17 March 2021 By Emma Koehn Sydney Morning Herald A Brisbane startup says it can make the active ingredients for the new generation of mRNA vaccines in Australia, but more government funding and training support are…
CSIRO moves towards Open Access for national benefit
Date posted – 17 March 2021 Media Release date – 3 March 2021 Research aimed at solving Australia’s greatest challenges will be made increasingly accessible as part of a shift towards ‘Open Access’ models at the national science…
ANDHealth Collaborates with US Healthcare Leader Anthem Inc. to Bring Innovative Australian Technologies to the US Market
Date posted – 17 March 2021 ANDHealth last week announced a joint effort with the Anthem Digital Incubator to facilitate and accelerate US market access and uptake for Australian digital health companies and their products and services. Anthem,…
PharmaLex broadens biopharma expertise
Date posted – 9 March 2021 The addition of ERA Consulting allows PharmaLex to further expand its geographic footprint as well as strengthens its biopharma capabilities Frankfurt, Germany – February 24, 2021: PharmaLex Group, a leading provider of…
Cartherics Announces Grant of European Patent
Date posted – 8 March 2021 First patented product to enter clinic within two years Cartherics Pty Ltd (Cartherics) announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects…
Monash University retains its spot as #2 in the world for Pharmacy and Pharmacology
Date posted – 4 March 2021 The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running. Pharmacy and Pharmacology remains Monash’s…
ALHI $28.9M MRFF GRANT REVOLUTIONISES LUNG FUNCTION SCANNING
Date posted – 4 March 2021 The Australian Lung Health Initiative (ALHI) is pleased to announce it has been granted $28.9 million in funding from the Australian Federal Government’s Medical Research Future Fund (MRFF) Frontier Health and Medical…
Graduate Certificate in Biotechnology (Enterprise) – University of Melbourne
Date posted – 3 March 2021 Graduate Certificate / Year: 2020 / Delivered: Online Be empowered to thrive in the business of biotech The Graduate Certificate in Biotechnology (Enterprise), delivered by The University of Melbourne, allows you to…
The American Chemical Society (ACS) is seeking nominations for C&EN’s 10 Start-ups to Watch
Date posted 3 March 2021 Deadline 1 August 2021 ACS is looking for companies that are using chemistry to solve the world’s most pressing problems. Firms that have made our list are developing pharmaceuticals, materials, green chemistry processes,…
Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes
Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…
